{"interviewQueryText":"What are some good interview questions in British English for the job description below?\n\n-------------------------------------------\n\nConsultant Older Adult Community Psychiatrist, Lancaster & Morecambe with Lancashire & South Cumbria NHS Foundation Trust in Lancaster and Morecambe\n\n Consultant Psychiatrist - Older Adult Psychiatry, Lancaster and Morecambe (10 PAs) * Golden Hello payment Payable * This post is eligible for a 5% payment of basic salary payable over 2 years Eligibility criteria do apply. Please note that staff currently employed by the Trust would not be eligible to apply for this recruitment and retention premia. We are seeking to recruit a substantive Consultant Older Adult Psychiatrist to work with the teams in Lancaster and Morecambe. The post is full time and the postholder will support the Community Mental Health Team (CMHT), Rapid Intervention and Treatment Team (RITT) and Memory Assessment Service (MAS). There will be an expectation to join the Consultant On Call rota, for which additional remuneration is payable. The clinical component of the post is focused on the care of the patients referred to the Rapid Intervention and Treatment Team, Community Mental Health Team and Memory Assessment Service with work base in Morecambe and/or Lancaster as will be agreed during job planning. Please see the Job Description for further details about each of these teams and the work that they do. Applicants should hold full GMC registration and be included on the Specialist register of the GMC or they should be eligible for entry to the Specialist Register within 6 months of the interview date. It is a requirement that applicants are Section 12 Approved at the time of commencing employment and have or are eligible to have Approved Clinician Status. Remuneration will be as set out in the terms of the New Consultant Contract according to previous experience. About us Please see the attached Job Description and Person Specification for further details about this post. The Job Description was approved by the Royal College of Psychiatrists on 10 January 2024. "}